NL-OMON40138
Completed
Not Applicable
IMproved Pregnancy Outcomes by Early Detection; personalised medicine for pregnant women: novel metabolomic and proteomic biomarkers to detect pre-eclampsia and improve outcome. - IMPROvED
niversity College Cork, Ireland0 sites1,000 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- hypertension in pregnancy
- Sponsor
- niversity College Cork, Ireland
- Enrollment
- 1000
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •nulliparous women
- •16 year or older
- •singleton pregnancy
- •between 9\+0 and 16\+6 weeks gestation
Exclusion Criteria
- •unsure term of pregnancy, 3 or more miscarriages or terminations, known or suspected fetal anomaly, essential hypertension or hypertension at booking, diabetes, renal disease, Systemic Lupus Erythematosus, Anti\-phospholipid Syndrome, Sickle Cell Disease, HIV positive, Hepatitis B or C positive, major uterine anomaly, cervical suture in situ, knife cone biopsy, long term steroids, treatment low\-dow aspirin/LMVW heparin
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The MOMENTS Study: Improving the outcome of pregnancy and early infancy with an intervention using mentors in socially deprived areas of BelfastInfant development and maternal wellbeingPregnancy and ChildbirthInfant developmentISRCTN55055030The Royal Group of Hospitals Trust (UK)340
Completed
Not Applicable
ong-term developmental outcomes of early detection and intervention in Permanent Childhood Hearing ImpairmentNL-OMON40510eids Universitair Medisch Centrum62
Completed
Not Applicable
Benefit of early detection and nephrologic intervention of acute kidney injury in hospital (BE NECIA)Diseases of the circulatory systemKCT0002010Seoul National University Bundang Hospital20,000
Completed
Not Applicable
Early Warning Scores in Pregnant WomanPregnancy ComplicationsNCT06488690Suleyman Demirel University304
Completed
Phase 4
Examination of the effectiveness of early diagnosis and treatment performed by magnetic resonance imaging (MRI) of hepatocellular carcinoma with liver specific contrast agent.Targeted to chronic liver disease patients undergoing abdominal ultrasonography in regular intervals, diagnosed the early hepatocellular carcinoma or more than 2cm 1.0cm.JPRN-UMIN000009830Gastroenterology of the university of Tokyo hospital140